FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues

被引:118
作者
Cook, JR
Lee, JH
Yang, ZH
Krause, CD
Herth, N
Hoffmann, R
Pestka, S
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA
[2] Univ Leipzig, Ctr Biotechnol & Biomed, Fac Chem & Mineral, D-04103 Leipzig, Germany
[3] PBL Biomed Labs, Piscataway, NJ 08854 USA
[4] Canc Inst New Jersey, New Brunswick, NJ 08903 USA
关键词
PRMT; protein arginine methyltransferase; type II; symmetric dimethylarginine; immunolocalization; structure modeling; methylation; FBXO11; FLJ12673; F-box; zinc finger; beta-propeller;
D O I
10.1016/j.bbrc.2006.01.167
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have identified a protein, FLJ12673 or FBXO 11, that contains domains characteristically present in protein arginine methyltransferases (PRMTs). Immuno-purified protein expressed from one of the four splice variants in HeLa cells and in Escherichia coli exhibited methyltransferase activity. Monomethylarginine, symmetric, and asymmetric dimethylarginine (SDMA, ADMA) were formed on arginine residues. Accordingly, we have designated the protein PRMT9. PRMT9 is the third member of the PRMT family that forms SDMA modifications in proteins. Structurally, this protein is distinct from all other known PRMTs implying that convergent evolution allowed this protein to develop the ability to methylate arginine residues and evolved elements conserved in PRMTs to accomplish this. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:472 / 481
页数:10
相关论文
共 39 条
[1]   Involvement of receptor-bound protein methyltransferase PRMT1 in antiviral and antiproliferative effects of type I interferons [J].
Altschuler, L ;
Wook, JO ;
Gurari, D ;
Chebath, J ;
Revel, M .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (02) :189-195
[2]   A proteomic analysis of arginine-methylated protein complexes [J].
Boisvert, FM ;
Côté, J ;
Boulanger, MC ;
Richard, S .
MOLECULAR & CELLULAR PROTEOMICS, 2003, 2 (12) :1319-1330
[3]   Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B′ and the Sm-like protein LSm4, and their interaction with the SMN protein [J].
Brahms, H ;
Meheus, L ;
De Brabandere, V ;
Fischer, U ;
Lührmann, R .
RNA, 2001, 7 (11) :1531-1542
[4]   PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins [J].
Branscombe, TL ;
Frankel, A ;
Lee, JH ;
Cook, JR ;
Yang, ZH ;
Pestka, S ;
Clarke, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) :32971-32976
[5]   The SCF ubiquitin ligase: Insights into a molecular machine [J].
Cardozo, T ;
Pagano, M .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (09) :739-751
[6]   Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300 [J].
Chen, DG ;
Huang, SM ;
Stallcup, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :40810-40816
[7]   Negative regulation of transcription by the type II arginine methyltransferase PRMT5 [J].
Fabbrizio, E ;
El Messaoudi, S ;
Polanowska, J ;
Paul, C ;
Cook, JR ;
Lee, JH ;
Nègre, V ;
Rousset, M ;
Pestka, S ;
Le Cam, A ;
Sardet, C .
EMBO REPORTS, 2002, 3 (07) :641-645
[8]   The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity [J].
Frankel, A ;
Yadav, N ;
Lee, JH ;
Branscombe, TL ;
Clarke, S ;
Bedford, MT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (05) :3537-3543
[9]   The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins [J].
Friesen, WJ ;
Paushkin, S ;
Wyce, A ;
Massenet, S ;
Pesiridis, GS ;
Van Duyne, G ;
Rappsilber, J ;
Mann, M ;
Dreyfuss, G .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (24) :8289-8300
[10]   SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets [J].
Friesen, WJ ;
Massenet, S ;
Paushkin, S ;
Wyce, A ;
Dreyfuss, G .
MOLECULAR CELL, 2001, 7 (05) :1111-1117